Alpha Feto Protein, Tumour Marker in New Delhi

Also known as AFP, Tumour Marker

You need to provide

Blood

This test is for

Male, Female

Test Preparation

No special preparation required

Understanding Alpha Feto Protein, Tumour Marker in New Delhi

What is Alpha Feto Protein, Tumour Marker in New Delhi?

An Alpha Feto Protein (AFP), Tumor marker is used to measure the levels of AFP in blood. Tumor markers help detect and diagnose cancers of the liver, testicles, and ovaries. These substances are made by cancer cells or by normal cells in response to cancer in the body. AFP is a protein made in the liver of a developing baby. The levels of AFP decline with age and adults should ideally have very low level of AFP.

Elevated levels in adults may sometimes indicate cancers of stomach, colon, lung, and breast. If AFP levels do not significantly decrease after cancer treatment, this may indicate presence of some of the tumor tissue. If the levels begin to increase after cancer treatment, then it is likely that the cancer may be recurring.

Answers to Patient Concerns & Frequently Asked Questions (FAQs) about Alpha Feto Protein, Tumour Marker in New Delhi

Frequently Asked Questions about Alpha Feto Protein, Tumour Marker in New Delhi

Q. What other tests are advised in case of abnormal levels of AFP?

In case, the levels of AFP are raised due to chronic liver infection or damage; an ultrasound exam, a CT scan, an MRI scan or a biopsy for histopathological evaluation of tumor tissues are advised. A blood test for DCP (des-gamma carboxy prothrombin) is advised. It helps to detect liver cancer and monitor patients with hepatocellular carcinoma.

Q. What is hepatocellular carcinoma?

Hepatocellular carcinoma is the most common type of primary liver cancer. It mostly occurs in people with chronic liver diseases such as cirrhosis which is caused by hepatitis B or C infection.

Q. What is hepatoblastoma?

Hepatoblastoma is a very rare cancer which usually affects children less than 3-4 years of age. The development of this tumor starts in the liver. However, it does not spread to other parts of the body. This tumor is caused by a change in the gene. In addition to that, some other genetic health conditions can also increase a child’s risk of hepatoblastoma. These conditions include Beckwith-Wiedemann syndrome, familial adenomatous polyposis, glycogen storage diseases, and Aiicardi syndrome.

Q. How is the blood sample taken?

The healthcare provider takes a blood sample from the arm. The site from where the blood is to be withdrawn is cleaned with a swab of rubbing alcohol. This is then followed by inserting a small needle which has a tube attached to it for collecting blood. Once the sufficient blood for analysis is withdrawn, the needle is removed. The site is then covered with a gauze pad.

Q. Is there any risk associated with the withdrawal of blood sample procedure?

As such there is no risk but in few cases, bruising, bleeding, and infection at the puncture site can be seen. In very few cases, there can be swelling of the vein after the blood is withdrawn.

+ more